Global Medical-grade Cobalt-60 Market Strategic Research Report

Scope of the Report

The global Medical-grade Cobalt-60 market size is predicted to grow from US$ 94.62 million in 2025 to US$ 135 million in 2032; it is expected to grow at a CAGR of 5.2% from 2026 to 2032.

Medical-grade Cobalt-60 is a high-purity, radioisotopic source produced through the neutron activation of stable Cobalt-59 in a nuclear reactor. It is specifically refined for use in medical radiotherapy equipment, such as Gamma Knives and teletherapy units. To be classified as "medical-grade," the source must meet stringent international standards regarding its specific activity, isotopic purity (minimizing contaminants like Cobalt-58), and physical dimensions, ensuring a high, consistent dose rate of gamma radiation required for the precise destruction of malignant tumors and neurological lesions.

In 2025, global Medical-grade Cobalt-60 production reached approximately 3.7 million Curie, average price was 26.14 USD/Curie, with gross margin 40%

Medical-grade Cobalt-60 is a high-activity gamma-emitting isotope primarily used in radiotherapy systems such as Gamma Knife and stereotactic radiosurgery. Compared to industrial-grade Co-60, medical-grade material requires stricter purity control, higher regulatory compliance, and more precise encapsulation standards due to its direct use in clinical treatment environments. The market is highly concentrated and tightly regulated, with supply controlled by a small number of nuclear reactor operators in countries such as Canada, Russia, and China. Production depends on neutron activation of Co-59 in nuclear reactors, creating significant entry barriers and limited supply elasticity. Demand is structurally driven by global cancer incidence growth and expanding radiotherapy adoption in emerging markets. While linear accelerators (LINACs) have partially displaced Co-60 in developed countries, cobalt-based radiotherapy systems remain cost-effective and operationally simpler in developing regions. As a result, Co-60 continues to maintain a stable demand base with long replacement cycles. Supply dynamics are constrained by reactor availability, irradiation scheduling, and nuclear regulatory frameworks. Given the 5.27-year half-life, continuous replenishment is required, resulting in a “rolling supply model” rather than one-off production cycles, which supports structurally stable to tightening pricing conditions over the long term. Overall, the Medical-grade Cobalt-60 market is characterized by high barriers, oligopolistic supply, stable demand growth, and long-cycle nuclear infrastructure dependence.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Medical-grade Cobalt-60 market?

What factors are driving Medical-grade Cobalt-60 market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Medical-grade Cobalt-60 market opportunities vary by end market size?

How does Medical-grade Cobalt-60 break out by Type, by Application?

This report presents a comprehensive overview of the global Medical-grade Cobalt-60 market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• High Specific Activity Cobalt-60
• Low Specific Activity Cobalt-60

Segment by Source Form

• Sealed Source
• Source Module

Segment by Application

• Medical Devices
• Medical Radiotherapy
• Others

Segment by Application

• Source for Gamma Knife
• Source for Cobalt Radiotherapy System
• Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Medical-grade Cobalt-60 market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Source for Gamma Knife, Source for Cobalt Radiotherapy System, Other evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact